@article{JTD26881,
author = {Biagio Ricciuti},
title = {Osimertinib for EGFR-mutant non-small cell lung cancer: place in therapy and future perspectives},
journal = {Journal of Thoracic Disease},
volume = {11},
number = {Suppl 3},
year = {2019},
keywords = {},
abstract = {In the last 20 years the clinical management of patients with advanced non-small cell lung cancer (NSCLC) has shifted form a histology-driven to a molecularly-based approach due to the identification of actionable genetic alterations and the subsequent development of highly efficacious targeted therapies.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/26881}
}